Neuropediatrics 2003; 34(6): 326-329
DOI: 10.1055/s-2003-44672
Short Communication

Georg Thieme Verlag Stuttgart · New York

Subacute Sclerosing Panencephalitis in Two Brothers

S. Vieker 1 , 2 , J. J. Schmitt 2 , C. Behrens 3 , B. Weissbrich 4 , H. Hartmann 3
  • 1Kinderklinik Gilead, Bielefeld, Germany
  • 2Klinik Mara 1, Bielefeld, Germany
  • 3Medizinische Hochschule Hannover, Hannover, Germany
  • 4Institut für Virologie und Immunbiologie, Würzburg, Germany
Further Information

Publication History

Received: April 29, 2003

Accepted after Revision: October 4, 2003

Publication Date:
18 December 2003 (online)

Abstract

We report the occurrence of subacute sclerosing panencephalitis (SSPE) in two brothers two years after measles infection. The diagnosis was confirmed by compatible data from medical history, occurrence of autochthonic measles virus (MV) IgG production in the central nervous system (CNS), and pathognomonic EEG changes. Pathogenetically, SSPE is caused by a genome mutation of intracellularly persisting MV, causing viral nucleocapsides to accumulate in the brain cells. A specific predisposing immune defect is not known. The occurrence of two cases in one family is suggestive of a genetic predisposing factor.

References

  • 1 Anlar B, Saatçi I, Köse G, Yalaz K. MRI findings in subacute sclerosing panencephalitis.  Neurology. 1996;  47 1278-1283
  • 2 Anlar B, Yalaz K, Oktem F, Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular α-interferon.  Neurology. 1997;  48 526-528
  • 3 Bartram C R, Henke J, Treuner J, Basler M, Esch A, Mortier W. Subacute sclerosing panencephalitis in a brother and sister. Therapeutic trial of fibroblast interferon.  Eur J Pediatr. 1982;  138 187-190
  • 4 Britt W J. Slow viruses. Feigin RD, Cherry JD Textbook of Pediatric Infectious Diseases. Philadelphia, PA; WB Saunders Company 1998: 1646-1665
  • 5 Gascon G G. Subacute sclerosing panencephalitis.  Semin Pediatr Neurol. 1996;  3 260-269
  • 6 Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanan I. et al . Combined oral isoprinosine- intraventricular α-interferon therapy for subacute sclerosing panencephalitis.  Brain Dev. 1993;  15 346-355
  • 7 Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good R A. et al . Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.  J Neurovirol. 2000;  6 121-126
  • 8 Jin L, Beard S, Hunjan R, Brown D WG, Miller E. Characterization of measles virus strains causing SSPE: A study of 11 cases.  J Neurovirol. 2002;  8 335-344
  • 9 Lauberau B, Hermann M, Weil J, Schmitt H J, von Kries R. Durchimpfungsraten von Kindern in Deutschland 1999.  Monatsschr Kinderheilkd. 2001;  149 367-372
  • 10 Park S Y, Kohl S. Subacute sclerosing panencephalitis in an identical twin.  Pediatrics. 1999;  104 1390-1394
  • 11 Sidhu M S, Crowley J, Lowenthal A, Karcher D, Menonna J, Cook S. et al . Defective measles virus in human subacute sclerosing panencephalitis brain.  Virology. 1994;  202 631-641
  • 12 Takahashi T, Hosoya M, Kimura K, Ohno K, Mori S. et al . The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.  Antiviral Res. 1998;  37 29-35
  • 13 Tischer A, Siedler A, Santibanez S, Grüber A, Rasch G. Sind Masern in Deutschland noch ein Problem?.  Monatsschr Kinderheilkd. 2002;  150 1077-1086
  • 14 Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T. Combined treatment with interferon α and ribaverin for subacute sclerosing panencephalitis.  Pediatr Neurol. 2001;  24 54-59

Dr. med. S. Vieker

Kinderklinik Gilead

Grenzweg 10

33617 Bielefeld

Germany

Email: Heinzel@Kinderklinik.gilead.de

    >